BioPharmics LLC was founded in 1998 to develop algorithms and software for computational drug design. In the areas of molecular docking and similarity, methods for scoring molecular interactions or superpositions are coupled to algorithms for rapid optimization of conformation and alignment of small molecules. BioPharmics LLC has implemented efficient and unique solutions with state-of-the-art performance.

We are committed to public disclosure of our scientific methodology in peer-reviewed academic journals. We are also committed to the use of fair benchmark comparisons to facilitate technical progress in the field.